06, October 2023. The TFA Technical Advocacy and Advisory Group (TAAG) meeting for quarter 4 of the current year was successfully held at the Heartfile office. The aim of the meeting was to acknowledge the progress made in establishing a policy for industrially produced trans fatty acids (iTFA) in Pakistan, while recognizing that the current policy is less restrictive. Participants aimed to strive for the Best Practice Policy Option, agreeing to approach the Pakistan Standards and Quality Control Authority (PSQCA) to either form a new committee or explore alternative regulatory pathways to adopt best practice policy standards.